Kansas City, KSNCT06426628Now EnrollingIRB Ready

Pulmonary Nodule, Solitary Clinical Trial in Kansas City, KS

Access cutting-edge pulmonary nodule, solitary treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by Veracyte, Inc.

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access pulmonary nodule, solitary specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary nodule, solitary treatment provided free

Apply for This Kansas City Location

Check if you qualify for this pulmonary nodule, solitary clinical trial in Kansas City, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Pulmonary Nodule, Solitary Study in Kansas City

The goal of this observational study is to learn how a physician uses the results of the Percepta® Nasal Swab test to manage people with a newly identified pulmonary nodule. The main questions it aims to answer are: * Does the use of the Percepta Nasal swab test reduce the number of invasive procedures in people with a low-risk result and whose nodule is benign? * Does the use of the Percepta Nasal swab test decrease the time to treatment in people with a high-risk result and whose nodule is cancer? Participants will be randomly assigned to either a group where the test result is provided to the physician (test arm) or to a group where the test result is not provided (control arm). Researchers will compare management of participants in the two groups.

Sponsor: Veracyte, Inc.

Who Can Participate

Inclusion Criteria

Able to tolerate nasal epithelial specimen collection
Signed written Informed Consent obtained
Subject clinical history available for review by sponsor and regulatory agencies
New nodule identified on imaging \< 90 days prior to nasal sample collection
CT report available for index nodule
29 - 85 years of age
Current or former smoker (\>100 cigarettes in a lifetime)
Pulmonary nodule ≤30 mm detected by CT

Exclusion Criteria

Active cancer (other than non-melanoma skin cancer)
Prior primary lung cancer (prior non-lung cancer acceptable)
Prior participation in this study (i.e., subjects may not be enrolled more than once)
Current active treatment with an investigational device or drug
Patient enrolled or planned to be enrolled in another clinical trial that may influence management of the patient's nodule
Concurrent or planned use of tools or tests for assigning lung nodule risk of malignancy other than clinically validated risk calculators

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT06426628) has an active research site in Kansas City, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Nodule, Solitary Treatment Options in Kansas City, KS

If you're searching for pulmonary nodule, solitary treatment options in Kansas City, KS, this clinical trial (NCT06426628) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary nodule, solitary specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, KS